Icon
+91 94997 68112
Login Register

CELEBREX (nda020998)- (50MG,100MG,200MG,400MG)

CELECOXIB UPJOHN
50MG,100MG,200MG,400MG
Yes No
2018-Apr-14 Expired
None None
None No
CELEBREX is a nonsteroidal anti-inflammatory drug indicated for: • Osteoarthritis (OA) • Rheumatoid Arthritis (RA) • Juvenile Rheumatoid Arthritis (JRA) in patients 2 years and older • Ankylosing Spondylitis (AS) • Acute Pain (AP) • Primary Dysmenorrhea (PD)
21 0 21
Total Other Developers 14
Drugs with Suitability No
50MG ** ** - - 13
100MG ** ** - - 15
200MG ** ** Up - 15
400MG ** ** - - 12
NDA Sales Available Total Generic Sales Available
Yes 14
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ********** ********** *** *** *********** ** ****** **, ****** ****, *** ****, ********* (***) ***
****** ***** *** ***** ******* *********** **** **. **-*, ***** *-*, ***** ********** ****, *****, ********, *** ******, ***** (***) ***
****** ***** *** ***** ******* *********** ****-*, **** **. ***, ***, ****** - **, ******* ******** ****, *****, ******, *********** ******, ***** (***) ***
****** ****** ****** ***. *********** ** ******** ****., *********, ******* *** ***, ****** (***) ***
****** ******* ******* *************** ******* *********** *********** ********, ******* *******, *.*. *******, **** *****, ****** *****,, **********, ******* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** ******* *****, **** ****** **********,****** *****, ******** *****, ******** ******* ******, ***** (***) ***
****** ***** **** ***** **** ******* *********** **** **. *-*** ** *-*** & **, ***** *** & ***** **, ***** ********** ******, *****, *** ******, ***** (***) ***
****** ******* ****** *** ******* ***************, ***. *********** ** ***** *****, *********, *** **** (**) *****-****, ****** ****** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ***** ***** ******* *** *********** **** *-*, *-**, *-** **** ********** ****, ******** *******, ******-*****, ****, *********** ******, ***** (***) ***
****** ***** ***** ******* *********** **** *-*, *-**, *-** **** ********** ****, ******** *******, ******-*****, ****, *********** ******, ***** (***) ***
****** ***** ***** ******* *********** **** **. * &** ****** ******* ******** ****, ***** **, ********* ****, ****** ******* ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********-******* *******, ******, ******-****, ****. *******, ******, ******* ******, ***** (***) ***
****** ******* ******* ******* ******** *************** **., ***. *********** **.***, ******** ****, ****, *******, ******, ***** (***) ***
****** ****** ****** *** ****** *************** ******* *********** ****, ****** ****, ******, *********, ******* ******, ***** (***) ***
****** ******* ****** ***** ******* ****** ************** **.,***. *********** **. ** ***** ****, **** ********, *******, ******** ******, ***** (***) ***
****** **** **** **** **** ************** **., ***. *********** **.** ****** ****, ******** *** ************* *********** ****, ************, ***** ******, ***** (***) ***
****** ******* ******* ************ ******* ******* *********** **** **. *** *** ***/*, ****, **** *****,, ****, ******* ******, ***** (***) ***
****** ****** ****** ************** *** *********** **.** ******** ****, ************, ******, ***** (***) ***
****** ******* ******* ************ ******* *********** **** **. ** ** **, ******* ********** ******, *******, ******, *** ******, ***** (***) ***
****** ****** ****** ***. *********** *** ****** *****, *******, ******* *** ***, ****** (***) ***
****** ***** ***** ***** ************** **., ***. ******* *********** ** ******** **** *** ******, ***, *******, ******, ***** (***) ***
****** ******* ******* ************** **., ***. *********** **. ** ******* ****, ******* ******** *** ****, *******, ******* ******, ***** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.